Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Abstract Text:

BACKGROUND: Buprenorphine is a safe, effective and underutilized treatment for opioid dependence that requires special credentialing, known as a waiver, to prescribe in the United States. OBJECTIVE: To describe buprenorphine clinical practices and barriers among office-based physicians. DESIGN: Cross-sectional survey. PARTICIPANTS: Two hundred thirty-five office-based physicians waivered to prescribe buprenorphine in Massachusetts. MEASUREMENTS: Questionnaires mailed to all waivered physicians in Massachusetts in October and November 2005 included questions on medical specialty, practice setting, clinical practices, and barriers to prescribing. Logistic regression analyses were used to identify factors associated with prescribing. RESULTS: Prescribers were 66% of respondents and prescribed to a median of ten patients. Clinical practices included mandatory counseling (79%), drug screening (82%), observed induction (57%), linkage to methadone maintenance (40%), and storing buprenorphine notes separate from other medical records (33%). Most non-prescribers (54%) reported they would prescribe if barriers were reduced. Being a primary care physician compared to a psychiatrist (AOR: 3.02; 95% CI: 1.48-6.18) and solo practice only compared to group practice (AOR: 3.01; 95% CI: 1.23-7.35) were associated with prescribing, while reporting low patient demand (AOR: 0.043, 95% CI: 0.009-0.21) and insufficient institutional support (AOR: 0.37; 95% CI: 0.15-0.89) were associated with not prescribing. CONCLUSIONS: Capacity for increased buprenorphine prescribing exists among physicians who have already obtained a waiver to prescribe. Increased efforts to link waivered physicians with opioid-dependent patients and initiatives to improve institutional support may mitigate barriers to buprenorphine treatment. Several guideline-driven practices have been widely adopted, such as adjunctive counseling and monitoring patients with drug screening.

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of general internal medicine : official jo

VOLUME: 23

Page Numbers: 1393-8

Journal Abbreviation:

ISSN: 1525-1497

DAY: 18

MONTH: Sep

YEAR: 2008

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8605834

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.

AFFILIATION: Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA, awalley@bu.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Gen Intern Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers Related Publications

• A new instrument and a new method of doing episiotomies.
• A new technique for replacement transfusion in the treatment of hemolytic disease of the newborn infant.
• Allergy in Japan.
• Allergy in Japan.
• Ambulance clinical placements - a pilot study of students' experience.
• Behaviour of Australian rainforest stream frogs may affect the transmission of chytridiomycosis.
• Chemotherapy-induced peripheral neuropathy was described as background noise affecting daily life.
• Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.
• Cottonseed protein food products.
• Infrequency of two deletion mutations at the DFNB1 locus in patients and controls.
• Insulin sensitivity in schizophrenia.
• Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.
• Otoconia in young and elderly persons: a temporal bone study.
• Percutaneous unknotting of intravascular catheters and retrieval of catheter fragments.
• Pituitary masses: the importance of a multidisciplinary approach.
• Sodium hypochlorite denatures the DNA of the amphibian chytrid fungus Batrachochytrium dendrobatidis.
• Specificity of a lipase from Geotrichum candidum for cis-octadecenoic acid.
• Sports drinks, exercise training, and competition.
• Studies on aerosols; effect of dust and pneumodilating aerosols on long volume and type of respiration in man.
• Studies on aerosols; reduction of dust deposition in lungs of rabbits by aqueous aerosols.
• The results of electric shock therapy.
• The use of nettle stings for pain.